In line with our results from our mouse models, these data from clinical tumor samples further support the importance of fine-tuning the redox state in concert with inactivation of A2AR signaling in intratumoral CD8+ T cells for favoring the antitumor immune response. This evidence concerns the gene ADORA2A and neoplasm.